- All > Medicine Information and Evidence for Policy > Medicines Policy
- All > Medicine Access and Rational Use > Rational Use
- All > Quality and Safety: Medicines > Quality Assurance
(2001; 4 pages) [French] [Spanish]
As envisaged in the FIP Guidelines for Good Pharmacy Practice (Tokyo 1993) with regard to the supply and use of medicines, all pharmacists should contribute to Good Labelling of Prescribed Medicines (GLPM).
Member Associations should adapt these guidelines to their national circumstances.
The purpose of a label for a prescribed medicine is:
- To describe and identify it
- To contribute to optimal therapeutic outcome and to avoid medication errors
- To achieve appropriate handling and storage
- To allow the product to be traced if there are problems with either the manufacturing, prescribing or dispensing process
Prescribed medicines are those that are prescribed for a specific patient, irrespective of their legal status as prescription-only or non-prescription medicines.
Label information for prescribed medicines should be considered to supplement and reinforce oral communication between the patient and healthcare provider.
The guidelines and recommendations relate only to the labels of the inner and outer container of the prescribed medicine, as seen by the patient before taking the medicine. They do not cover medicines taken or administered under the direct control of health professionals, nor do they cover patient package leaflets.